Ritual and suggestion
Meaning, expectation, relationship, authority, and sensory experience can be active parts of a treatment encounter. Distinct traditions should not be collapsed into placebo.
The problem behind the summit
Because some change symptoms, some alter measurable physiology, and some do neither. We still cannot reliably tell which person, condition, or outcome belongs in which category.
That is not proof that thought heals disease. It is the reason to study the boundary carefully.
A long history
Meaning, expectation, relationship, authority, and sensory experience can be active parts of a treatment encounter. Distinct traditions should not be collapsed into placebo.
Hypnosis, biofeedback, stress physiology, and the biopsychosocial model made experience and behavior legitimate clinical variables.
MBSR and placebo research moved parts of the question into trials, while exposing the difference between felt relief and disease change.
Psychoneuroimmunology and neural stimulation established causal routes across nervous, endocrine, and immune systems. They did not establish voluntary control of those routes.
Ted Kaptchuk's analysis of healing ritual is one route into this history. It shows why the treatment encounter deserves study without treating Navajo ceremony, acupuncture, and biomedicine as interchangeable systems.
Reports of spontaneous remission also belong in the history, but “spontaneous” means that the course is unexplained. It does not identify intention, belief, infection, immunity, treatment, or any other cause. The uncertainty is the research question.
What the evidence says
Pain Reprocessing Therapy produced large and durable pain reductions in one randomized trial of primary chronic back pain. It did not test inflammatory, autoimmune, structural, or post-infectious illness.
In Kaptchuk and colleagues' asthma study, placebo rituals improved reported relief but not airway function. Albuterol changed airway function. Both outcomes mattered, but they were not interchangeable.
Conditioned cues changed selected immune assays, and voluntary attention changed an acute histamine skin response. Neither study tested recovery from chronic pain and illness.
Implanted cervical stimulation improved rheumatoid arthritis outcomes in the RESET-RA trial. A noninvasive auricular trial did not improve its primary disease-activity outcome. A device result cannot be reassigned to breathing, meditation, or calm by analogy.
A useful counterexample: an MBSR pilot in rheumatoid arthritis improved distress and well-being but did not change disease activity. Read the study.
Why the stakes are large
A person can have active pathology and centrally amplified symptoms at the same time. Another can have residual injury, autonomic dysregulation, learned avoidance, medication effects, deconditioning, sleep disruption, or a new exposure in different proportions.
The same intervention can therefore relieve symptoms, improve function without changing disease activity, do nothing, provoke a flare, or delay needed care. A useful study must say which outcome moved and what remained unchanged.
Commercial brain-retraining and nervous-system-regulation programs already market to people with ME/CFS, Long COVID, chronic pain, and related conditions. Their success stories may help generate candidate responder patterns, but stories without denominators, nonresponders, records, and comparison cannot establish efficacy or selection.
A broad mind-body explanation can communicate dismissal, delay diagnosis or treatment, hide adverse effects, and turn nonresponse into a failure of effort or belief.
Treating every contextual or behavioral intervention as imaginary can withhold symptom relief, function, agency, or a useful adjunct from people who could benefit.
The research task is to reduce both errors, not to choose a side in the old binary.
The missing clinical problem
There is no validated general “mind-body responder” profile. Expectancy or therapeutic alliance may predict improvement, but they do not diagnose a hidden cause or tell us that one named intervention will outperform another.
What active pathology, residual injury, or mixed process has been assessed?
Is the aim symptom relief, function, physiology, disease activity, or remission?
What attention, movement, exposure, expectation, relationship, or explanation is actually delivered?
What predicts benefit, nonresponse, flare, deterioration, or delayed care?
When should change occur, how durable should it be, and what result redirects treatment?
The working concept
Does a comparable challenge repeatedly produce the same threshold, gain, delay, or prolonged tail?
Do fast responses and slower susceptibility return toward a characteristic regime after perturbation?
Does the route into a response regime differ from the route out?
Does the same input work differently during a measurable phase or window of change?
A flare curve alone does not establish an attractor. The stronger claim requires a specified model that predicts recurrent or restoring dynamics, transitions, or intervention effects better than pathology, exposure, sensitization, learning, ordinary feedback, treatment, or natural history. The conceptual paper Have you tried switching it off and on again? provides a candidate framework and research agenda, not a settled account of chronic pain and illness.
What follows
The primary shared paper now in development is Between symptom and disease: a research agenda for testing mind-body interventions in chronic pain and illness. It begins with a field map, then identifies the reviews and experiments needed to test the boundary.
Run a preregistered evidence map, then synthesize only comparable conditions, interventions, outcomes, and time horizons.
Follow a narrow result into reviews, pamphlets, commercial programs, media, and testimonials. Mark every extra inference.
Test treatment moderators, recruit nonresponders and harms, and validate any candidate rule in a new sample.
Compare program practices, explanations, evidence, safety, cost, medical coordination, blame, and exit rights.
Measure natural flares, threshold, gain, delay, recovery, recurrence, and intervention effects across timescales, then compare formal models.
Measure flares, functional loss, delayed care, financial cost, dependency, shame, and loss of trust alongside benefit.